Blacksmith Medicines
San Diego
About Blacksmith Medicines
Blacksmith Medicines developing medicines targeting metal-dependent enzymes found in human physiology. Over 30% of known enzymes are metalloenzymes, covering all major enzyme classes: oxidoreductases, transferases, hydrolases, lyases, isomerases, and ligases. Metal ions, including magnesium, zinc, iron, manganese and copper, are the essential ingredient in these metalloenzymes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $3.3M
- Funding stage: Seed
- Last round: Grant (Feb 2024)
- Website: blacksmithmedicines.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Genetics, Life Science
Social Profiles
Canonical: https://fsome.com/organization/blacksmith-medicines-55520 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.